Integrity (IGAP) 4.3500 $IGAP
Faith Comes By Hearing Enlists Expertise of IAI to Reach World's 'unconnected' with Digital Bible
PRWeb - Tue May 12, 9:31AM CDT
After launching their aerospace division at the beginning of this year and establishing their Advisory Council of esteemed space and aeronautical professionals in March, Faith Comes By Hearing continues to press forward with their ambitious agenda to provide digital Bible access to the most remote and hard-to-reach regions on the planet. Continuing this quick pace of progress, FCBH has awarded a contract to Integrity Applications Incorporated (IAI) to determine the best way to provide the Digital Bible to 'unconnected' people in the Middle East & North Africa, Southeast Asia, and China by leveraging space and telecommunications capabilities.
Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China
PR Newswire - Tue Feb 17, 8:25AM CST
Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or "Integrity"
, developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack model DF-F device with LifeCaring Technologies Limited (H.K.) and Guangzhou Guang Yuan Biological Pharmaceutical Co. Ltd. in Hong-Kong and in China, respectively. According to the International Diabetes Federation, as of 2013 a total of about 0.5 million people with diabetes, or 9.5 percent of the adult population, in Hong-Kong, and a total of about 98 million people with diabetes, or 9.5 percent of the adult population, in China have diabetes.
Integrity Applications, Inc. Announces Completion of Successful $8.5 Million Equity Financing
PR Newswire - Mon Jan 05, 9:52AM CST
Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or "Integrity", developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that, on December 31, 2014, it raised an aggregate of $1,647,450 through the sale in a private placement transaction of 1,647.45 units (each a "Unit" and, collectively, the "Units", at a price of $1,000 per Unit. Each Unit consists of: (a) one share of Integrity's Series B 5.5% Convertible Preferred Stock (the "Series B Preferred Stock", (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock.
Integrity Applications, Inc. Announces Equity Financing of $3.0 Million
PR Newswire - Wed Sep 03, 7:19AM CDT
Integrity Applications, Inc. (OTCQB: IGAP) ("Integrity", announced today that, on August 29, 2014, it raised an aggregate of $3,036,000 through the sale in a private placement transaction of 3,036 units (each a "Unit" and, collectively, the "Units", at a price of $1,000 per Unit. Each Unit consists of: (a) one share of Integrity's newly designated Series B 5.5% Convertible Preferred Stock (the "Series B Preferred Stock", (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock.
Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.
PR Newswire - Mon Jul 21, 7:00AM CDT
Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or "Integrity", developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that it has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into a Manufacturing Agreement with Wistron Corp, the manufacturing arm of Acer Inc. Pursuant to the agreement, Wistron has agreed to manufacture and service (on a non-exclusive basis) the GlucoTrack Model DF-F and any future products, if any, introduced by the Company. Wistron has agreed to provide full turn-key manufacturing services for the GlucoTrack model DF-F, including components procurement, units assembly, device integration, testing and packaging.
Faith Comes By Hearing Enlists Expertise of IAI to Reach World's 'unconnected' with Digital Bible
PRWeb - Tue May 12, 9:31AM CDT
After launching their aerospace division at the beginning of this year and establishing their Advisory Council of esteemed space and aeronautical professionals in March, Faith Comes By Hearing continues to press forward with their ambitious agenda to provide digital Bible access to the most remote and hard-to-reach regions on the planet. Continuing this quick pace of progress, FCBH has awarded a contract to Integrity Applications Incorporated (IAI) to determine the best way to provide the Digital Bible to 'unconnected' people in the Middle East & North Africa, Southeast Asia, and China by leveraging space and telecommunications capabilities.
Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China
PR Newswire - Tue Feb 17, 8:25AM CST
Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or "Integrity"
, developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack model DF-F device with LifeCaring Technologies Limited (H.K.) and Guangzhou Guang Yuan Biological Pharmaceutical Co. Ltd. in Hong-Kong and in China, respectively. According to the International Diabetes Federation, as of 2013 a total of about 0.5 million people with diabetes, or 9.5 percent of the adult population, in Hong-Kong, and a total of about 98 million people with diabetes, or 9.5 percent of the adult population, in China have diabetes. Integrity Applications, Inc. Announces Completion of Successful $8.5 Million Equity Financing
PR Newswire - Mon Jan 05, 9:52AM CST
Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or "Integrity"
, developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that, on December 31, 2014, it raised an aggregate of $1,647,450 through the sale in a private placement transaction of 1,647.45 units (each a "Unit" and, collectively, the "Units", at a price of $1,000 per Unit. Each Unit consists of: (a) one share of Integrity's Series B 5.5% Convertible Preferred Stock (the "Series B Preferred Stock", (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock. Integrity Applications, Inc. Announces Equity Financing of $3.0 Million
PR Newswire - Wed Sep 03, 7:19AM CDT
Integrity Applications, Inc. (OTCQB: IGAP) ("Integrity"
, announced today that, on August 29, 2014, it raised an aggregate of $3,036,000 through the sale in a private placement transaction of 3,036 units (each a "Unit" and, collectively, the "Units", at a price of $1,000 per Unit. Each Unit consists of: (a) one share of Integrity's newly designated Series B 5.5% Convertible Preferred Stock (the "Series B Preferred Stock", (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock. Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.
PR Newswire - Mon Jul 21, 7:00AM CDT
Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or "Integrity"
, developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that it has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into a Manufacturing Agreement with Wistron Corp, the manufacturing arm of Acer Inc. Pursuant to the agreement, Wistron has agreed to manufacture and service (on a non-exclusive basis) the GlucoTrack Model DF-F and any future products, if any, introduced by the Company. Wistron has agreed to provide full turn-key manufacturing services for the GlucoTrack model DF-F, including components procurement, units assembly, device integration, testing and packaging. 
